Get started
Author

Ali Murat Sedef

Observed names: A Murat Sedef, A. Sedef, A.M. Sedef, ALI MURAT SEDEF, Ali M. Sedef, Ali Murat SEDEF, Ali Sedef, SEDEF, ALİ MURAT, Sedef Ali Murat
Observed institutions: Başkent University, Adana Hospital, Medical Park Tarsus Hastanesi, Şanlıurfa Mehmet Akif İnan Eğitim ve Araştırma Hastanesi, Sağlık Bilimleri Üniversitesi, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital
ORCID: 0000-0002-3955-2705
Observed ORCIDs: 0000-0002-3955-2705, 0000-0002-0798-2380
OpenAlex ID: A5004081480
Prediction of Peritoneal Recurrence in Patients with Gastric Cancer: a Multicenter Study
2020 · Tulay Kus, Fatih Kose, et al. · Journal of Gastrointestinal Cancer · 25
A study on basic demographic and disease characteristics of cancer-diagnosed Syrian refugees treated in the border city of Turkey, Sanliurfa; a hospital-based retrospective case series study.
2017 · Yasemin Bakkal Temi, Ali Murat Sedef, et al. · PubMed · 21
Procalcitonin as a biomarker for infection-related mortality in cancer patients
2015 · Ali M. Sedef, Fatih Kose, et al. · Current Opinion in Supportive and Palliative Care · 15
The Hematologic Parameters in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Abiraterone Acetate
2019 · Cem Onal, Ali Murat Sedef, et al. · Future Oncology · 13
Prognostic factors for survival in patients with mucosal and ocular melanoma treated with ipilimumab: Turkish Oncology Group study
2019 · H Arzu Yaşar, Hande Turna, et al. · Journal of Oncology Pharmacy Practice · 12
Outcome of loco-regional radiotherapy in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate
2019 · Berna Akkus Yildirim, Cem Onal, et al. · Strahlentherapie und Onkologie · 11
Primary Extranodal Non-Hodgkin's Lymphoma: Clinicopathological Features, Survival and Treatment Outcome in Two Cancer Centers of Southern Turkey
2014 · Huseyin Mertsoylu, Sadik Muallaoglu, et al. · Asian Pacific Journal of Cancer Prevention · 11
PDF
Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study
2018 · Yuksel Urun, H Arzu Yasar, et al. · Journal of Oncology Pharmacy Practice · 10
The clinicopathological and survival differences between never and ever smokers with non-small cell lung cancer.
2014 · Sadik Muallaoglu, Cemile Karadeniz, et al. · PubMed · 10
Multiple extraneural metastases of anaplastic oligodendroglioma
2018 · Fatih Aydemir, Ozgur Kardes, et al. · Asian Journal of Neurosurgery · 6
Unexpected skin lesions after axitinib treatment
2017 · Ali Murat Sedef, Fatih Köse, et al. · Journal of Oncological Sciences · 5
Prognostic value of procalcitonin in infection-related mortality of cancer patients.
2016 · Ali Murat Sedef, Fatih Kose, et al. · PubMed · 5
Patients with distal intestinal gastric cancer have superior outcome with addition of taxanes to combination chemotherapy, while proximal intestinal and diffuse gastric cancers do not: does biology and location predict chemotherapy benefit?
2015 · Ali Murat Sedef, Fatih Köse, et al. · Medical Oncology · 4
Targeted treatment with pazopanib in metastatic soft tissue sarcoma: Nearly complete response in two cases
2014 · ALI MURAT SEDEF, FATIH KÖSE, et al. · Molecular and Clinical Oncology · 4
PDF
Prognostic and predictive role of FOXP3 positive tumor infiltrating lymphocytes (TILs) in curatively resected non small cell lung cancer other than stage IA
2017 · Fatih Kose, Tuba Canbolat, et al. · Journal of Oncological Sciences · 3
PDF
By 2022, Cancer is Now a More Chronic Disease with Chronic Difficulties to Go Along with It
2022 · Ahmet Taner SÜMBÜL, Ali Murat SEDEF, et al. · Journal of Oncological Sciences · 2
PDF
The hematologic parameters in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate.
2019 · Onal Cem, Ali Murat Sedef, et al. · Journal of Clinical Oncology · 2
Addition of taxanes to combination chemotherapy in distal intestinal gastric cancer is more beneficial than proximal ones: A multicenter retrospective study of Turkish Oncology Group.
2019 · Ali Murat Sedef, Fatih Kose Ahmet Taner Sumbul, et al. · PubMed · 2
The Prognostic Significance of Complete Response Rates in Patients with Extensive Stage Small Cell Lung Cancer
2019 · Ali Murat Sedef · Turkish Journal of Oncology · 2
PDF
Angioneurotic edema of metastatic breast cancer patient associated with letrozole
2017 · Yasemin Bakkal Temi, Ali Murat Sedef · Journal of Oncological Sciences · 2
PDF
Acute fatal interstitial lung disease in two cases under treatment of crizotinib
2016 · Ali Murat SEDEF, Fatih Köse, et al. · Clinical Case Reports and Reviews · 2
PDF
Pre-Treatment Lymphopenia and NLR May Have Prognostic Value in Turkish High-Grade Glial Tumor Patients
2021 · Ali Murat Sedef · Eurasian Journal of Medical Investigation · 1
The outcome of loco-regional radiotherapy in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate.
2019 · Berna Yildirim, Onal Cem, et al. · Journal of Clinical Oncology · 1
Conventıonal and targeted therapy in metastatıc colorectal cancer
2018 · Ali Murat SEDEF, Ahmet Taner SÜMBÜL · Journal of Cancer Prevention & Current Research · 1
PDF
Prognostic value of basal neutrophil lymphocyte ratio in patients with extensive stage small cell lung cancer
2018 · Ali Murat SEDEF, Züleyha ÇALIKUŞU, et al. · Çukurova medical journal (Online)/Çukurova medical journal · 1
PDF
Works count: 64
Citation count: 176
H-index: 9
I10-index: 9
Year
Topic
Type